Penicillamine
DrugBank ID: DB00859
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| megaloblastic anemia (disease) | 0.9802 | DL |
| galactosemia | 0.9643 | DL |
| glycogen storage disease | 0.9428 | DL |
| tricarboxylic acid cycle disorder | 0.9346 | DL |
| disease of transporter activity | 0.9302 | DL |
| neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | 0.9301 | DL |
| glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form | 0.9288 | DL |
| glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form | 0.9288 | DL |
| adult polyglucosan body disease | 0.9249 | DL |
| granulomatous disease, chronic, X-linked | 0.9248 | DL |
| hereditary hemochromatosis | 0.9237 | DL |
| autosomal recessive severe congenital neutropenia due to G6PC3 deficiency | 0.9231 | DL |
| pyruvate metabolism disorder | 0.9154 | DL |
| anemia, nonspherocytic hemolytic, due to G6PD deficiency | 0.9026 | DL |
| inborn disorder of fatty acid oxidation and ketone body metabolism | 0.9022 | DL |
| disorder of mineral absorption and transport | 0.9022 | DL |
| hemolytic anemia due to diphosphoglycerate mutase deficiency | 0.9002 | DL |
| HIV infectious disease | 0.8994 | DL |
| primary immunodeficiency syndrome due to p14 deficiency | 0.8953 | DL |
| Wilson disease | 0.8941 | DL |
| glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form | 0.8938 | DL |
| glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form | 0.8938 | DL |
| glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form | 0.8938 | DL |
| glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form | 0.8938 | DL |
| glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form | 0.8938 | DL |
| glycogen storage disease due to glucose-6-phosphatase deficiency | 0.8852 | DL |
| G6PD deficiency | 0.8841 | DL |
| obsolete rare hereditary hemochromatosis | 0.8810 | DL |
| oculocerebral hypopigmentation syndrome, Cross type | 0.8780 | DL |
| Griscelli syndrome | 0.8775 | DL |
| cold agglutinin disease | 0.8760 | DL |
| Hermansky-Pudlak syndrome with pulmonary fibrosis | 0.8713 | DL |
| iron metabolism disease | 0.8709 | DL |
| ermine phenotype | 0.8705 | DL |
| Hermansky-Pudlak syndrome without pulmonary fibrosis | 0.8698 | DL |
| primary CD59 deficiency | 0.8694 | DL |
| piebaldism | 0.8684 | DL |
| ocular albinism with sensorineural deafness | 0.8672 | DL |
| paraplegia | 0.8652 | DL |
| albinism | 0.8633 | DL |
| glycogen storage disease due to muscle and heart glycogen synthase deficiency | 0.8629 | DL |
| classic galactosemia | 0.8545 | DL |
| feline acquired immunodeficiency syndrome | 0.8543 | DL |
| simian immunodeficiency virus infection | 0.8543 | DL |
| galactokinase deficiency | 0.8528 | DL |
| ocular albinism (disease) | 0.8516 | DL |
| minimal pigment oculocutaneous albinism type 1 | 0.8511 | DL |
| temperature-sensitive oculocutaneous albinism type 1 | 0.8505 | DL |
| primary hyperoxaluria | 0.8492 | DL |
| hemochromatosis | 0.8473 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.